- Home
- NFJ vs STAA Comparison
NFJ vs STAA Comparison
Compare NFJ & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NFJ
- STAA
- Stock Information
- Founded
- NFJ 2005
- STAA 1982
- Country
- NFJ United States
- STAA United States
- Employees
- NFJ N/A
- STAA N/A
- Industry
- NFJ Finance: Consumer Services
- STAA Ophthalmic Goods
- Sector
- NFJ Finance
- STAA Health Care
- Exchange
- NFJ Nasdaq
- STAA Nasdaq
- Market Cap
- NFJ 1.2B
- STAA 1.2B
- IPO Year
- NFJ N/A
- STAA N/A
- Fundamental
- Price
- NFJ $12.76
- STAA $16.87
- Analyst Decision
- NFJ
- STAA Buy
- Analyst Count
- NFJ 0
- STAA 8
- Target Price
- NFJ N/A
- STAA $38.83
- AVG Volume (30 Days)
- NFJ 223.5K
- STAA 1.3M
- Earning Date
- NFJ 01-01-0001
- STAA 02-11-2025
- Dividend Yield
- NFJ 9.01%
- STAA N/A
- EPS Growth
- NFJ N/A
- STAA N/A
- EPS
- NFJ N/A
- STAA N/A
- Revenue
- NFJ N/A
- STAA $313,901,000.00
- Revenue This Year
- NFJ N/A
- STAA $22.83
- Revenue Next Year
- NFJ N/A
- STAA $13.41
- P/E Ratio
- NFJ N/A
- STAA N/A
- Revenue Growth
- NFJ N/A
- STAA N/A
- 52 Week Low
- NFJ $10.45
- STAA $13.50
- 52 Week High
- NFJ $12.86
- STAA $52.68
- Technical
- Relative Strength Index (RSI)
- NFJ 42.56
- STAA 32.25
- Support Level
- NFJ $12.77
- STAA $15.20
- Resistance Level
- NFJ $13.01
- STAA $18.38
- Average True Range (ATR)
- NFJ 0.12
- STAA 1.29
- MACD
- NFJ -0.02
- STAA -0.47
- Stochastic Oscillator
- NFJ 5.56
- STAA 32.28
About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. Its primary investment objective is to seek current income and gains, with a secondary objective of long-term capital appreciation. The fund pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.